Tag Archives: OTC

New Pseudoephedrine Drug Could Hop Back Over the Counter

Yesterday Acura Pharmaceuticals launched its new pseudoephedrine-based product Nexafed, an over-the-counter product aimed at deterring abuse of the illicit drug methamphetamine. Pseudoephedrine, the decongestant known also as the primary ingredient in the production of methamphetamine, has been subject to a federal statute which keeps medicines with the ingredient behind the counter of all pharmacies in […]
Posted in Market Access, Safety, Strategy | Tagged | 1 Comment

US v. Caronia: What Constitutes 'Truthful' Speech?

If a drug’s label is not the final word on what is true – or untrue – about a product, then who decides what can and cannot be said during a sales detail?
Posted in Advertising, compliance, FDA, Legal, Marketing, Regulatory, Safety, Sales, Strategy | Also tagged , , , , , , , , , , , , , , , , , | 1 Comment

As American as Acid Reflux

Over the counter drug advertising is less regulated than prescription drug marketing, and selling directly to consumers comes with the benefit of bypassing an expert middleman: your doctor. But companies should still promote with caution.
Posted in Advertising, Corporate Responsibility, E-Media, FDA, healthcare, leadership, Market Access, Marketing, patient education, Regulatory, Strategy | Also tagged , , , , | 1 Comment
  • Categories

  • Meta